The aim of the study was to assess the time course effect of IKr blockade on ECG biomarkers of ventricular repolarization and to evaluate the accuracy of a fully automatic approach for QT duration evaluation.
ological and pathophysiological limitations. Indeed, accurate QT end evaluation is not simple. Manual measurement remains recommended as a standard. 4 As a consequence the precise QT duration evaluation is based on time-consuming and expensive expert analyses. Hence a reliable automatic method for QT duration measurement is strongly needed.
An even more critical weakness is in that QT/QTc duration alone is clearly not a good surrogate for the risk of drug-induced torsades de pointes. 5, 6 Experimental data strongly suggest that spatial and/or temporal heterogeneities of ventricular repolarization may provide more accurate indexes for arrhythmic substratum in drug-induced QT prolongation condition as well as in numerous other arrhythmic conditions. [7] [8] [9] [10] [11] [12] Accordingly, the search for ECG biomarkers of ventricular repolarization heterogeneities has become a main area of investigation. Both experimental and in silico models suggest that morphology parameter of the T wave might enable to assess the degree of ventricular repolarization dispersion. 13, 14 Hence, both scalar measurements and principal component analysis (PCA) have been used to describe T-wave morphology and changes in T-wave morphology parameters have been associated with impaired repolarization and bad prognosis. [15] [16] [17] [18] [19] [20] The relative time course of QT prolonging drugs effect on these new biomarkers has been so far poorly evaluated.
The aim of this study was twofold: (1) to assess the time course effect of IKr blockade (a condition associated with both QT prolongation, increased dispersion of ventricular repolarization, and a risk of torsades de pointes) on ECG biomarkers of ventricular repolarization (2) to evaluate the accuracy of a fully automatic approach for QT duration evaluation. We took advantage of a previous study 21 in which single-dose administration design enables the assessment of sotalol effect at different plasma concentration.
METHODS

Study Population and Design
The study population consisted of 38 healthy subjects (27 males, mean age = 27.4 ± 8.0 years) in whom 12-lead digital ECG Holter was recorded on two or three consecutive days. No drug was given on the first day (baseline), while 160 mg of dl Sotalol was given on the second day (single dose) 1 hour after the start of the recording and 320 mg was given on the third day (double dose) to a subset of the initial group. Sotalol blood plasma concentration was also measured at fixed time points. Full details of the study protocol have been previously described. 21 
ECG Recordings
From the 24-hour Holter 12 leads recording (H12 recorders, Mortara Instrument, Milwaukee, WI, USA), 10-second long strips were automatically extracted at predefined time points using the Antares software (AMPS llc, New York, NY, USA). The exported ECGs were the least noise-affected strips among those with normal beats and preceded by stable heart rate. ECG snapshots were extracted every 10 minutes starting at 8 AM and ending at noon, just prior to meal intake leading to 25 ECGs per recording for each subject ( Fig. 1 panel A) .
Biomarkers
All measurements were computed on representative median beats derived from the available consecutive cardiac cycles of each 12 leads snapshot.
To characterize ventricular repolarization, three biomarker categories were considered ( Fig. 1  panel B ): (i) conventional ECG time intervals: QT interval, corrected QT, and heart rate; (ii) 3D markers derived from a PCA analysis on the T wave; and (iii) fully automatic biomarkers computed from a mathematical model of the T wave named bi-Gaussian function (BGF).
For each representative beat QRS onset/offset and T offset calipers were set manually by an experienced cardiologist (FE). These cursors were used only for conventional and PCA analyses whereas the Bi-Gaussian modeling was fully automatic.
Conventional Manual ECG Time Intervals: QT, RR, QTci, QTcB
QT duration was corrected for heart rate using correcting formula derived from the powerlaw (log-log) QT/RR model: QTc = QT/RR α where α = 0.5 for the Bazett's correction (QT cB ) or α = i estimated from the individual QT/RR relationship (QTci). 22, 23 
3D Manual Vectocardiographic Approach
PCA analysis was based on singular value decomposition. [24] [25] [26] [27] Using PCA on 12-lead ECGs, the orthogonal eigenvectors delineate an eight-dimensional space whereas the eigenvalues (λ 1 , . . . , λ 8 ) represent the energy in each dimension. Singular value decomposition was applied independently on QRS complex and T wave to obtain the eigenvectors and the eigenvalues for each part of the signal. The angle θ between QRS and T is defined as the angle between the principal vector of the QRS complex, and the principal vector extracted from the T wave.
The projection of the T wave on the subspace defined by the last five eigenvectors is commonly named the nondipolar components The "T-wave residuum" (TWR) is defined as the ratio between the energy of the nondipolar component to the total energy of the T wave:
In each dimension, the dispersion of the T-wave PCA loop is given by sigma (σ i , expressed in mV)
The ratio of the second to the first σ (σ 2/σ 1) is the socalled PCA ratio and provides an estimate of the roundness of the PCA T-wave loop.
BGF Mathematical Model
The P, QRS, and T-wave extraction from each representative cardiac complex is obtained with a fully automatic procedure. [28] [29] [30] Subsequently, the projection of the T wave on the PCA principal dimension is modeled by a fourparameter function called bi-Gaussian function estimated by minimization of the least-square error between the BGF model and the T-wave signal.
For a given T wave, the BGF model is computed with the following outputs: "A" as the T-wave amplitude surrogate measured at T peak , "early-T" fitting the ascending phase of the T-wave and "late-T" describing the descending phase of the T wave ( Fig. 1, panel C) . The ratio between the ascending and descending phases (early/late) was also computed. Finally, the sum in milliseconds of QT peak interval + 2·late-T was calculated as a surrogate for the total QT interval duration.
Statistical Analysis
Normality distribution was verified for all parameters (ECG, PCA, and GMF), and correlation matrices were computed. Averaged values of parameters were compared between time-matched baseline and the two drugdosing levels using the paired t-test with a confidence interval of 95%.
Subsequently, all parameters were analyzed involving the development of generalized linear model (GLM), using Minitab statistical software (Minitab Inc., State College, PA, USA). We built various GLM models for the identification of the best parameter that could first identify the presence of drugs. We then compared the time-matched data, to identify the first time point and the timeinterval at which each GLM model (one for each analyzed parameter) would be significant in identifying the presence of the drug, both for single and double dose. All GLMs were corrected for RR as covariate and the comparison was computed using Bonferroni's method and with a confidence interval of 95%.
In all tests a P value < 0.05 was considered statistically significant. Table 1 shows the sotalol effect at maximum plasma concentration on ventricular repolarization parameters. Sotalol administration was followed by an increase of the RR, QT, and QTci interval durations. PCA parameters changes were not statistically significant at T max for both single and double dose of sotalol.
RESULTS
Sotalol Effect on Ventricular Repolarization Parameters at Maximum Drug Concentration
The T-wave mathematical model outputs were significantly prolonged at T max after both low and high sotalol dosing. Paralleling sotalol-induced QT prolongation, the QT mathematical surrogate QT was prolonged up to 80 ms. The ascending phase of the T wave (early-T) was prolonged in average by 31 ms and 48 ms with sotalol 160 mg and 320 mg respectively, whereas the descending phase of the T wave (late-T) was prolonged by 10 ms and 15 ms, respectively.
Time Course of Sotalol Effect on Ventricular Repolarization Parameters
The upper panel of Figure 2 displays the sotalol plasma concentration after sotalol 160 mg administration. The first time point at which ECG models significantly identified a drug effect, both for single and double dose is presented in Table 2 and Figure 2 .
The duration of the QT interval is significantly prolonged 1 hour 10 minutes after 320 mg drug dosing and 1 hour 20 minutes after 160 mg dosing. Rate corrected QTci showed almost identical results.
PCA ventricular repolarization parameters sotalol-induced changes were delayed when compared to QT changes.
Automatic modeling data provide further information. After sotalol dosing, early-T changes preceded late-T prolongation. Accordingly, the early/late ratio changed significantly 2 hours after sotalol 160 mg dosing but no significant change was observed after the second sotalol dosing. Globally, the modeled surrogate QT paralleled manual QT changes (Figure 2) . T-wave amplitude time course changes showed a biphasic pattern at sotalol low dose, and a decrease at high dose, more pronounced at later stages. Table 3 displays the maximum time-matched sotalol effect on all ventricular repolarization parameters. With the exception of the early/late T-wave ratio, all parameters showing a significant increase continued to increase reaching a maximum sotalol 
Accuracy of the Fully Automatic Method
In Figure 3 (panel A) the relationship between manual QT and automatic surrogate QT is shown. The two measures were strongly correlated (automatic QT = 1.06 * manual QT − 48.5, R 2 = 0.92, P < 0.001). Panel B displays the Bland and Altman plot: the systematic bias was 26.5 ms with 1.96 * SD lower and upper bound equal 10.5 ms and 42.5 ms, respectively. The bias was, however, slightly but significantly dependent on QT duration (y = −0.102 * x + 63.8, R 2 = 0.108, P < 0.001).
DISCUSSION
Main Results
After single-dose sotalol administration QT/QTc duration is the first parameter derived from sur-face ECG that is significantly modified. Parameters extracted from mathematical modeling on the T wave occurred almost simultaneously. The bi-Gaussian function modeling of T wave provided additional information. T-wave morphology components showed different time constants; the ascending phase of the T wave being the first influenced by sotalol, followed by T-wave symmetry changes and finally changes in the descending phase of the T wave. Finally, PCA derived T-wave parameters changes occurred at later times.
Effect of Sotalol on Ventricular Repolarization Biomarkers
Our results on the marked effects of sotalol on RR, QT, and QTc intervals are in good agreement with the previously published literature. 21, 23, 31 The delay observed between the maximal drug plasma concentration and the maximal effect on ventricular repolarization is more interesting. This hysteresis was observed on the same database whatever the method used for QT correction 21, 23 and is a well-identified phenomenon, 32 which represents a great concern for the use of pharmacokinetic/pharmacodynamic models in drug-induced QT prolongation evaluation. The lack of significant changes in PCA T-wave parameters observed in this study at maximum sotalol plasma concentration could be a consequence of such hysteresis. Nevertheless, the poor PCA performance with such a strong IKr blocking drug is somewhat disappointing. Part of this result may be related to the relatively high intrinsic variability in PCA T-wave parameters. 24 Beyond QT interval duration, recently developed mathematical modeling showed that potassium channel loss of function is associated with profound T-wave morphology variation. [33] [34] [35] 
Time Course of Ventricular Repolarization Biomarkers after Single-Dose Sotalol Administration
The earliest effect of IKr blockade on ventricular repolarization is a prolongation of the ascending phase of the T wave. The effect on the descending phase of the T wave only occurred around 1 hour later.
The significance of these different kinetics responses after sotalol administration is unclear but clearly shows that IKr blockade effect on repolarization biomarkers displays different time constants. It might be critical to take into account such kinetics heterogeneities in particular when trying to differentiate between low and high risk for druginduced torsades de pointes.
The lack of significant change of PCA ratio and QRS-T angle may be a consequence of a limited observation period as it can be suggested by the delayed increase in TWR observed at the end of the recording period. In this regard, it would have been interesting to prolong the exploratory period.
Unfortunately, the study protocol included a meal 4 hours after drug dosing that produced an important effect mainly represented by dramatic heart rate acceleration. This heart rate effect together with the well-known autonomic influence of meal intake and the also thoroughly documented effect of both heart rate and autonomic nervous system on ventricular repolarization prevented us to evaluate sotalol effects on ventricular repolarization parameters after the 4-hour period described in our protocol. [36] [37] [38] This, however, represents a main limitation of our study.
Effect of Sotalol on T-Wave Amplitude
The description of sotalol effect on T-wave amplitude deserves further clarification. It is likely that the effects of sotalol on the T-wave amplitude are twofold.
First, a heart rate-related effect, the amplitude of T-wave apex relative to baseline has been shown to be rate dependent in normal subject. 39 This effect was also observed in this study after pooling baseline and placebo data ( Fig. 4 upper panel) . Since sotalol decreases heart rate, the T-wave amplitude increases ( Fig. 4 lower panel) .
Second, a direct electrophysiological effect consisting in a decrease in T amplitude induced by IKr blockade. This effect has been described by Vaglio et al. using a rate binning approach. 34 In our study, during the last 2 hours of the recordings, T-wave amplitude decreases while heart rate remains stable suggesting a delayed and long-lasting effect of sotalol on T-wave amplitude ( Fig. 4 lower panel) . The direct effect is initially masked by the early heart rate decrease, and it is more clearly revealed once the heart rate becomes stable.
These phenomena explain why despite sotalol decreases T-wave amplitude, the rate uncorrected T-wave amplitude at maximal sotalol plasma concentration showed a counterintuitive augmentation ( Table 1) .
The reason why IKr blockade decreases T-wave amplitude is not clear. Simulation studies rather suggest that IKr blockade should increase T-wave amplitude. 40 These complicated explanations emphasize the difficulties encountered when trying to analyze and interpret ventricular repolarization changes.
Fully Automatic Approach for T-Wave Morphology Characterization
Our results show that mathematical modeling of the T-wave allows detecting subtle electrophysiological effects.
Despite a strong correlation, the GMF-based QT surrogate QT is not equivalent to QT duration. Indeed, the two parameters display a significant and systematic bias with an average level of the QT surrogate of about 25 ms shorter than the measured QT duration. In addition, the bounds of the Bland and Altman plots are larger than 15 ms, thus corresponding to an unacceptable imprecision when keeping in mind the accuracy requested in thor-ough QT studies. 4 More critically, this bias was dependent on QT duration leading to potential underestimation of QT interval duration for QT durations longer than 370 ms.
Nevertheless, the fully automatic method we used was sufficient to detect sotalol effect on QT duration as early as the time-consuming manual method. This method could thus be proposed as the first-step crude analysis.
Conclusions
Using ECG extraction from long-term 12-lead Holter recordings we could show that changes in different ECG biomarkers of ventricular repolarization display different kinetics after administration of a potent potassium channel blocker. These differences need to be taken into account when designing ventricular repolarization ECG studies. Recent ECG technologies allow automatic calculation of most of the repolarization biomarkers.
